Mostrando 7 resultados de: 7
Filtros aplicados
Publisher
European Journal of Endocrinology(3)
Journal of Clinical Endocrinology and Metabolism(3)
Frontiers in Endocrinology(1)
Área temáticas
Enfermedades(6)
Fisiología humana(4)
Medicina y salud(2)
Bibliotecas y archivos generales(1)
Ginecología, obstetricia, pediatría, geriatría(1)
Origen
scopus(7)
Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation
ArticleAbstract: Objectives: The clinical presentation of patients with nonclassic 21-hydroxylase deficiency (N21OHD)Palabras claves:Autores:El-Maouche D., Gaynor A., Merke D.P., Nanba A.T., Richard J. Auchus, Turcu A.F., Veeraraghavan P., Zhao L.Fuentes:scopus24-Hour Profiles of 11-Oxygenated C<inf>19</inf> Steroids and Δ<sup>5</sup>-Steroid Sulfates during Oral and Continuous Subcutaneous Glucocorticoids in 21-Hydroxylase Deficiency
ArticleAbstract: Background: Optimal management of androgen excess in 21-hydroxylase deficiency (21OHD) remains challPalabras claves:11-oxyandrogens, 21-hydroxylase deficiency, CAH, Circadian hormones, Congenital adrenal hyperplasia, cortisol 24-hour profileAutores:Byrd J.B., Chen X., Mallappa A., Merke D.P., Nanba A.T., Nella A.A., Richard J. Auchus, Turcu A.F., Zhao L.Fuentes:scopusA Phase 2, Multicenter Study of Nevanimibe for the Treatment of Congenital Adrenal Hyperplasia
ArticleAbstract: Context: Patients with classic congenital adrenal hyperplasia (CAH) often require supraphysiologic gPalabras claves:adrenal hypertrophy, ATR-101, Clinical trial, Congenital adrenal hyperplasia, nevanimibeAutores:Chang A.Y., El-Maouche D., Joyal E.G., Lin V.H., Merke D.P., Mohideen P., Plaunt M.R., Richard J. Auchus, Turcu A.F., Vogiatzi M.G., Weintraub L.Fuentes:scopusCongenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society* clinical practice guideline
ArticleAbstract: Objective: To update the congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency cliPalabras claves:Autores:Arlt W., Baskin L.S., Conway G.S., Merke D.P., Meyer-Bahlburg H.F.L., Miller W.L., Murad M.H., Oberfield S.E., Richard J. Auchus, Speiser P.W., White P.C.Fuentes:scopusAdrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency
ArticleAbstract: Objective: To comprehensively characterize androgens and androgen precursors in classic 21-hydroxylaPalabras claves:Autores:Chomic R., Giordano T.J., Merke D.P., Nanba A.T., Rainey W.E., Richard J. Auchus, Shields J.J., Turcu A.F., Upadhyay S.K.Fuentes:scopusErratum: Androgen excess and diagnostic steroid biomarkers for nonclassic 21-hydroxylase deficiency without cosyntropin stimulation (European Journal of Endocrinology (2020) 18:1 (63-71) DOI: 10.1530/EJE-20-0129)
OtherAbstract: The authors apologise for an error in Table 2 of the above article published in the July 2020 issuePalabras claves:Autores:El-Maouche D., Gaynor A., Merke D.P., Nanba A.T., Richard J. Auchus, Turcu A.F., Veeraraghavan P., Zhao L.Fuentes:scopusErratum: Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: An endocrine society clinical practice guideline (The Journal of Clinical Endocrinology and Metabolism (2018) 103:11 (4043-4088) DOI: 10.1210/jc.2018-01865)
OtherAbstract: The above-mentioned guideline by Speiser PW, Azziz R, Baskin LS, Ghizzoni L, Hensle TW, Merke DP, MePalabras claves:Autores:Arlt W., Baskin L.S., Conway G.S., Merke D.P., Meyer-Bahlburg H.F.L., Miller W.L., Murad M.H., Oberfield S.E., Richard J. Auchus, Speiser P.W., White P.C.Fuentes:scopus